HCA Healthcare, Inc. $HCA Shares Sold by Burney Co.

Burney Co. lessened its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 12.0% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 28,542 shares of the company’s stock after selling 3,907 shares during the quarter. Burney Co.’s holdings in HCA Healthcare were worth $12,165,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Chung Wu Investment Group LLC purchased a new position in shares of HCA Healthcare during the 2nd quarter worth $27,000. Clearstead Trust LLC increased its position in shares of HCA Healthcare by 311.8% during the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after acquiring an additional 53 shares during the last quarter. Ameriflex Group Inc. acquired a new position in shares of HCA Healthcare in the 2nd quarter worth approximately $27,000. Saudi Central Bank acquired a new stake in HCA Healthcare in the 1st quarter valued at approximately $26,000. Finally, Harbor Capital Advisors Inc. lifted its stake in HCA Healthcare by 82.9% during the third quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock worth $32,000 after purchasing an additional 34 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the sale, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. This represents a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.30% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on HCA. Barclays increased their target price on HCA Healthcare from $445.00 to $494.00 and gave the stock an “overweight” rating in a research note on Monday, October 27th. KeyCorp lifted their price objective on shares of HCA Healthcare from $465.00 to $475.00 and gave the company an “overweight” rating in a report on Monday, October 27th. Robert W. Baird raised their price target on shares of HCA Healthcare from $423.00 to $450.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of HCA Healthcare in a research report on Monday. Finally, Mizuho boosted their target price on HCA Healthcare from $505.00 to $520.00 and gave the stock an “outperform” rating in a research note on Thursday, December 18th. Fourteen research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $479.00.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $477.30 on Friday. The business has a 50-day moving average of $475.66 and a two-hundred day moving average of $420.04. The company has a market capitalization of $108.92 billion, a price-to-earnings ratio of 18.45, a price-to-earnings-growth ratio of 1.40 and a beta of 1.36. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $520.00.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. During the same quarter in the prior year, the business posted $4.90 EPS. The company’s revenue for the quarter was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.13%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.